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What is already known about the topic?
•• Outcome measures need to be specifically developed in palliative care populations to reflect the concerns of advanced 
illness and ensure minimal respondent burden.
•• The Palliative care Outcome Scale (POS) and Palliative care Outcome Scale–symptom module (POS-S) are brief, valid and 
reliable questionnaires developed for this population.
•• However, there is some overlap, and patient and clinician feedback indicates scope for further refinement.
•• Cognitive interviewing is recommended for questionnaire development but not adopted widely in palliative care research.
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Abstract
Background: The Integrated Palliative care Outcome Scale is a newly developed advancement of the Palliative care Outcome Scale. 
It assesses patient-reported symptoms and other concerns. Cognitive interviewing is recommended for questionnaire refinement but 
not adopted widely in palliative care research.
Aim: To explore German- and English-speaking patients’ views on the Integrated Palliative care Outcome Scale with a focus on 
comprehensibility and acceptability, and subsequently refine the questionnaire.
Methods: Bi-national (United Kingdom/Germany) cognitive interview study using ‘think aloud’ and verbal probing techniques. 
Interviews were audio-recorded, transcribed verbatim and analysed using thematic analysis and pre-defined categories. Results from 
both countries were collated and discussed. The Integrated Palliative care Outcome Scale was then refined by consensus.
Setting/participants: Purposely sampled patients from four palliative care teams in palliative care units, general hospital wards and 
in the community.
Results: A total of 15 German and 10 UK interviews were conducted. Overall, comprehension and acceptability of the Integrated 
Palliative care Outcome Scale were good. Identified difficulties comprised the following: (1) comprehension problems with specific 
terms (e.g. ‘mouth problems’) and length of answer options; (2) judgement difficulties, for example, due to the 3-day recall for 
questions; and (3) layout problems. Combining the results from both countries (e.g. regarding ‘felt good about yourself’) and discussing 
them from both languages’ perspectives resulted in wider consideration of the items’ meaning, enabling more detailed refinement.
Conclusion: Cognitive interviewing proved valuable to increase face and content validity of the questionnaire. The concurrent 
approach in two languages – to our knowledge the first such approach in palliative care – benefited the refinement. Psychometric 
validation of the refined Integrated Palliative care Outcome Scale is now underway.
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What this paper adds:
•• In response to patients’ and clinicians’ demands, we present a refined measure (Integrated Palliative care Outcome Scale 
(IPOS)) that has been shaped by the patients’ perspectives.
•• This study demonstrates once more the importance of cognitive interviewing in the refinement of outcome measures and 
that it can be done effectively in a palliative care population.
•• The concurrent use of cognitive interviewing in two languages – for the first time in palliative care – provided additional 
valuable information, resulted in wider consideration of the meaning and context of each item and led to a better overall 
refinement of the IPOS questionnaire.
Implications for practice, theory or policy
•• IPOS is now available for clinical use; it is one of the few brief measures validated in this population that covers all relevant 
domains.
•• The refined version of the IPOS is currently undergoing phase II of validation in Germany and the United Kingdom to dem-
onstrate the psychometric properties.
•• Wider awareness and use of cognitive interviewing in measure refinement in palliative care is crucial, and cognitive inter-
viewing in more than one language can have added value.
Background
Patient-reported outcome measures (PROMs) are 
questionnaires completed by patients to measure their 
perceptions of their functional status and well-being.1  
The Integrated Palliative care Outcome Scale (IPOS) is 
a PROM and a newly developed advancement of the 
Palliative care Outcome Scale (POS) which assesses 
symptoms and other palliative care (PC) concerns as 
perceived by the patient. There are versions for patients 
and healthcare professionals.
The POS was developed in 1999 with the involvement 
of patients and has been validated in a variety of settings: 
hospice in-patient care, day care, home care, hospital in-
patient care and community and outpatient services.2 It has 
been used to inform clinical practice, to monitor service 
interventions, to evaluate and improve the quality of 
care and as a research tool.3,4 The POS team has currently 
endorsed 11 translations, and POS is being used in over 20 
countries.4,5 To describe the impact of PC-specific symp-
toms, a symptom module (the POS-S) was developed as an 
addition to the POS. Requests from clinical colleagues to 
merge POS and POS-S triggered the development of IPOS 
(see Figure 1). The IPOS is based on POS and POS-S, with 
changes to the wording of certain questions and response 
options. The 10 questions cover patients’ main concerns, 
common symptoms, patient and family distress, existential 
well-being, sharing feelings with family, information 
received and practical concerns.
Adopting a recommended quality criterion for ques-
tionnaires,6,7 we aimed to involve patients in the question-
naire development through cognitive interviewing to 
ensure face and content validity and acceptability. 
Cognitive interviewing is increasingly used as a step in the 
refinement of survey questions and PROMs.8 A complex 
cognitive process takes place when research participants 
answer questionnaires. This includes comprehension of 
the question, retrieval of information from memory, judge-
ment processes to estimate an answer and formulation of a 
response.9,10 The European Organisation for Research and 
Treatment of Cancer (EORTC) guidelines for question-
naire development recommend cross-language pre-test-
ing.11 Accordingly, we aimed to base the IPOS refinement 
on views from German- and English-speaking patients and 
have the refined questionnaires available for concurrent 
psychometric validation in both countries.
Figure 1. Design stages of the IPOS.
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Methods
Design
Cross-sectional, qualitative, bi-national and multicentre 
study enrolling purposively sampled PC patients in Germany 
and the United Kingdom, using cognitive interviews.
Setting and participants
In Germany, patients were recruited from a university hos-
pital PC unit and its associated hospital support and com-
munity PC teams. UK patients were recruited from a 
university hospital support team. Inclusion criteria were as 
follows: age 18 years or above, capacity to give consent and 
sufficient fluency in written and spoken English or German 
language to answer the questionnaire. Exclusion criteria 
were as follows: being too unwell or distressed to partici-
pate as judged by the clinical team. Participants were pur-
posively sampled according to the following criteria in 
order to achieve variation across key characteristics: gen-
der, over and under 65 years, high, medium and low func-
tional status as measured by the Australia-modified 
Karnofsky Performance Status (AKPS) scale12 (see Table 1) 
and malignant/non-malignant main diagnosis. It was not 
aimed to have equal numbers in all cells, but to include 
participants with all characteristics. Screening took place at 
multidisciplinary team meetings or handovers, and a clini-
cal team member asked whether the patients were inter-
ested and provided an information leaflet. Interested 
patients were approached by the researcher – except five 
who had deteriorated or been discharged. Of the 29 
approached patients, 25 gave their informed consent.
Cognitive interviews
Formal translation of the IPOS from English to German had 
previously been conducted using standard techniques.13 The 
interviews were conducted in the participants’ current care 
setting, that is, on the ward or in the participants’ home. 
Participants were asked to complete the questionnaire, using 
a combination of ‘think aloud’ and concurrent verbal prob-
ing techniques to elicit problems or comments regarding the 
completion.14,15 ‘Think aloud’ techniques (uttering the 
thoughts during question answering) were demonstrated by 
the interviewer at the start of the interview. Probing tech-
niques were both spontaneous, to explore verbal or non-
verbal utterances like hesitations or irritation, and stand- 
ardised according to an interview guide (see Appendix 1). 
This was based on the four-stage question response model 
as described by Tourangeau10 (comprehension, retrieval, 
judgement and response formulation). Probes were devel-
oped for each of the four stages, and additional questions 
related to layout, missing aspects in the questionnaire and 
burden associated with its completion. The interviews were 
audio-recorded and transcribed verbatim.
Analysis of the interviews and refinement of the 
IPOS
Interviews were analysed by two independent researchers 
in each country using thematic analysis as described by 
Willis.14 In accordance with the interview guide, the tran-
script was also categorised following Tourangeau’s10 ques-
tion response model (comprehension, retrieval, judgement 
and response formulation). Additional categories included 
the following: layout, acceptability/questionnaire burden 
and additional aspects. Results of all participants were 
compared and aggregated for each question and each cat-
egory in both countries to identify the reasons for difficul-
ties in answering the questionnaire and other emergent 
themes.
The German results were translated. Results from both 
countries were then collated and discussed between the 
research teams and the IPOS was refined accordingly, 
based on consensus. The German version was adapted 
according to the refined English version, taking German-
language-specific results into account.
The study was approved by the relevant ethics commit-
tees (Ethikkommission of Ludwig-Maximilians-
Universität Munich, reference number 169-13; National 
Research Ethics Service (London–Dulwich Committee) 
reference number: 13/LO/0573).
Results
Demographics
A total of 15 German and 10 UK interviews (16–54 min 
long) were completed between July 2013 and July 2014. 
The median age was 65 years in Germany (range 22–
85 years) and 61 years in the United Kingdom (range 43–
83 years). In Germany, 10/15 and in the United Kingdom, 
7/10 participants were female. The predominant primary 
diagnosis was cancer. A third of the participants in 
Germany and two-thirds in the United Kingdom had an 
AKPS score of 50% or lower, which is defined by requir-
ing ‘considerable assistance and frequent medical care’.12 
The majority of participants were in-patients. Details are 
shown in Table 1.
Findings from the interviews and IPOS 
refinement
The interviews in both countries demonstrated that for the 
majority of participants, most questions and answer 
options worked well. The identified difficulties were 
mainly comprehension problems and some pertained to 
judgement. No problems were identified with retrieval or 
response formulation. The interview results and the 
changes made based on them are shown in Table 2. The 
revised questionnaire can be found on the POS website.5
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Comprehension. Patients were certain about their main prob-
lems and concerns (question 1), and many described these as 
the things that are always on your mind. Positive comments 
about the symptom list in question 2 included the following:
Oh, easy to understand. (United Kingdom, female aged 
43 years)
and
I think question 2 is good, that it is all dealt with in a very 
‘compact’ way. (Germany, female aged 25 years)
‘Pain’, ‘shortness of breath’, ‘nausea’, ‘poor appetite’ 
and ‘constipation’ listed in question 2 were well under-
stood by all participants. Comprehension of question 3 
(anxiety/worries) was also good for all participants.
Some comprehension problems were identified in both 
countries. First, difficulties arose with the wording of spe-
cific questions. For example, the term ‘mouth problems’ in 
question 2 was regarded as too vague, and in contrast to the 
intent of the question, many patients did not think of dry 
mouth when answering it. Furthermore, comprehension 
problems concerned answer options which were regarded 
Table 1. Demographic and clinical details of participants.
Germany United Kingdom
Total number interviewed 15 10
Age (years) Median, range 65 (22–85) 61 (43–83)
⩽65 9 7
>65 6 3
Sex Female 10 7
Male 5 3
Nationality German 14  
British 7
Other 1 1
Not recorded 2
British 7
Other 1 1
Not recorded 2
Ethnicity White British Not recorded 7
Black African 2
Black Caribbean 1
Marital status Married 7 6
Partner 1 1
Separated or divorced 2 2
Widowed 0
Single 5 0
Not specified 1
Living situation Alone 4 4
With others 11 6
Working situation Retired Not recorded 4
Working 5
Unemployed 1
Primary diagnosis Malignant 13 9
Non-malignant  2 (cardiomyopathy and 
motor neuron disease)
1 (chronic obstructive 
pulmonary disease)
AKPS score Median, range 60% (40%–100%) 52% (40%–70%)
>70% 4 0
>50%⩽70% 6 3
⩽50% 5 7
Care setting Palliative care unit 10  
Other hospital ward with 
support from hospital palliative 
care team
2 10
Community 3  
The Australia-modified Karnofsky Performance Status Scale (AKPS) grades functional status, for example, 70% represents ‘cares for self, unable to 
carry on normal activity or to do active work’ and 50% represents ‘requires considerable assistance and frequent medical care’.12
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ed
 8
3 
ye
ar
s)
4/
15
 o
f G
er
m
an
 p
ar
tic
ip
an
ts
 d
es
cr
ib
ed
 d
iff
er
en
t 
ty
pe
s 
of
 n
au
se
a,
 a
nd
 t
he
re
fo
re
 fo
un
d 
th
e 
ex
pl
an
at
io
n 
in
 b
ra
ck
et
s 
pr
ov
id
ed
 c
la
ri
fic
at
io
n
I s
om
et
im
es
 fe
el
 s
ick
 b
ut
 d
o 
no
t h
av
e 
th
e 
fe
el
in
g 
th
at
 I 
ha
ve
 to
 v
om
it.
 (
G
er
m
an
y,
 fe
m
al
e 
ag
ed
 7
7 
ye
ar
s)
N
au
se
a 
(fe
el
in
g 
lik
e 
yo
u 
ar
e 
go
in
g 
to
 b
e 
si
ck
)
V
om
iti
ng
 (
be
in
g 
si
ck
)
O
ve
ra
ll 
go
od
 c
om
pr
eh
en
si
on
 b
y 
pa
rt
ic
ip
an
ts
 (
24
/2
5)
Vo
m
iti
ng
 is
 w
he
n 
yo
u 
ar
e 
ac
tu
al
ly 
sic
k.
 (
U
K
, f
em
al
e 
ag
ed
 4
7 
ye
ar
s)
V
om
iti
ng
 (
be
in
g 
si
ck
)
Po
or
 a
pp
et
ite
G
oo
d 
co
m
pr
eh
en
si
on
 b
y 
al
l p
ar
tic
ip
an
ts
Th
at
 I 
so
m
et
im
es
 d
o 
no
t f
ee
l l
ik
e 
ea
tin
g 
an
yt
hi
ng
. (
G
er
m
an
y,
 m
al
e 
ag
ed
 5
5 
ye
ar
s)
A
ns
w
er
 o
pt
io
n 
‘A
ffe
ct
s 
ac
tiv
ity
 a
nd
 c
on
ce
nt
ra
tio
n’
 n
ot
 a
pp
ro
pr
ia
te
 fo
r,
 fo
r 
ex
am
pl
e,
 p
oo
r 
ap
pe
tit
e 
(G
er
m
an
y,
 1
/1
5)
Po
or
 a
pp
et
ite
C
on
st
ip
at
io
n
G
oo
d 
co
m
pr
eh
en
si
on
 b
y 
al
l p
ar
tic
ip
an
ts
(r
eg
ar
di
ng
 ‘p
oo
r 
ap
pe
tit
e’
) …
 is
 c
le
ar
, c
le
ar
ly 
de
fin
ab
le
. C
on
st
ip
at
io
n,
 to
o.
 B
y 
di
ffe
re
nt
 d
ru
gs
, o
r 
ca
us
ed
 b
y 
th
e 
ch
em
ot
he
ra
py
. (
G
er
m
an
y,
 fe
m
al
e 
ag
ed
 6
6 
ye
ar
s)
2/
10
 o
f U
K
 p
at
ie
nt
s 
th
ou
gh
t 
ot
he
r 
bo
w
el
 p
ro
bl
em
s 
sh
ou
ld
 b
e 
in
cl
ud
ed
 h
er
e 
to
o
C
on
st
ip
at
io
n
 (C
on
tin
ue
d)
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Pr
ot
ot
yp
e 
IP
O
S 
ite
m
s
Pr
ot
ot
yp
e 
IP
O
S 
an
sw
er
 o
pt
io
ns
A
sp
ec
ts
 id
en
tif
ie
d 
w
ith
 s
up
po
rt
in
g 
qu
ot
at
io
ns
R
ev
is
ed
 IP
O
S 
ite
m
s
R
ev
is
ed
 IP
O
S 
an
sw
er
 o
pt
io
ns
M
ou
th
 p
ro
bl
em
s
T
oo
 v
ag
ue
 a
nd
 u
nc
le
ar
 (
5/
25
)
M
ou
th
 p
ro
bl
em
s?
 It
’s 
fu
nn
y 
th
ey
 m
en
tio
n 
m
ou
th
 p
ro
bl
em
s, 
w
hy
 w
ou
ld
 th
ey
 a
sk
 a
bo
ut
 m
ou
th
 p
ro
bl
em
s?
 
(U
K
, f
em
al
e 
ag
ed
 8
3 
ye
ar
s)
8/
15
 o
f p
at
ie
nt
s 
in
 G
er
m
an
y 
di
d 
no
t 
ne
ce
ss
ar
ily
 t
hi
nk
 o
f d
ry
 m
ou
th
 b
ut
 o
f s
or
e 
m
ou
th
/c
he
w
in
g/
sw
al
lo
w
in
g 
pr
ob
le
m
s/
to
ot
h 
ac
he
Th
e 
to
ng
ue
 is
 s
or
e,
 th
er
e 
w
ill 
be
 th
ru
sh
 o
r 
so
, a
nd
 w
ith
 th
e 
te
et
h-
 th
ey
 a
re
 n
ot
 a
ll 
ow
n 
te
et
h 
– 
an
d 
so
 o
n 
th
er
e 
ar
e 
pr
ob
le
m
s 
w
ith
 e
at
in
g.
 (
G
er
m
an
y,
 m
al
e 
ag
ed
 6
9 
ye
ar
s)
S
o
re
 o
r 
dr
y 
m
o
ut
h
D
ro
w
si
ne
ss
9/
10
 o
f U
K
 p
at
ie
nt
s 
ha
d 
go
od
 c
om
pr
eh
en
si
on
 o
f t
he
 w
or
d 
dr
ow
si
ne
ss
, U
m
 …
 w
he
n 
ju
st
 …
 w
he
n 
yo
u’
re
 e
ye
s 
ar
e 
lik
e 
go
in
g 
fo
gg
y 
an
d 
yo
u 
ju
st
 w
an
t t
o 
sle
ep
 …
 O
h 
it 
w
as
 e
as
y 
to
 u
nd
er
st
an
d.
 (
U
K
, f
em
al
e 
ag
ed
 4
3 
ye
ar
s)
2/
15
 o
f G
er
m
an
 p
at
ie
nt
s 
w
er
e 
un
ce
rt
ai
n 
if 
it 
m
ea
nt
 t
ir
ed
ne
ss
 b
y 
da
y 
or
 b
y 
ni
gh
t
Pr
ob
le
m
s 
go
in
g 
to
 s
le
ep
 o
r 
pr
ob
le
m
s 
sle
ep
in
g 
th
ro
ug
h 
th
e 
ni
gh
t –
 o
r 
th
e 
dr
ow
sin
es
s 
on
ly 
re
la
te
s 
to
 th
e 
da
yt
im
e.
 (
G
er
m
an
y,
 fe
m
al
e 
ag
ed
 7
7 
ye
ar
s)
D
ro
w
si
ne
ss
Po
or
 m
ob
ili
ty
15
/1
5 
of
 G
er
m
an
 p
ar
tic
ip
an
ts
 h
ad
 g
oo
d 
co
m
pr
eh
en
si
on
W
el
l, 
if 
I c
an
 ju
st
 s
ta
nd
 u
p 
an
d 
w
al
k 
aw
ay
 –
 o
r 
so
m
eh
ow
 r
ea
lly
 w
al
k,
 w
ith
ou
t a
id
s, 
le
t’s
 s
ay
. N
ow
 I 
ca
nn
ot
 
w
al
k 
al
on
e 
w
ith
ou
t t
he
 w
al
ki
ng
 fr
am
e 
or
 th
e 
w
he
el
ch
ai
r. 
Th
at
 is
 m
ob
ilit
y 
fo
r 
m
e.
 (
G
er
m
an
y,
 m
al
e 
ag
ed
 
69
 ye
ar
s)
In
te
rp
re
ta
tio
n 
of
 m
ob
ili
ty
 a
nd
 w
ea
kn
es
s/
la
ck
 o
f e
ne
rg
y 
as
 s
im
ila
r 
to
 U
K
 p
at
ie
nt
s 
(3
/1
0)
Po
or
 m
ob
ili
ty
Pl
ea
se
 li
st
 a
ny
 o
th
er
 
sy
m
pt
om
s 
no
t 
m
en
tio
ne
d 
ab
ov
e,
 
an
d 
tic
k 
on
e 
bo
x 
to
 
sh
ow
 h
ow
 t
he
y 
ha
ve
 
af
fe
ct
ed
 y
ou
 o
ve
r 
th
e 
pa
st
 3
 d
ay
s.
2/
15
 o
f G
er
m
an
 p
ar
tic
ip
an
ts
 c
om
m
en
te
d 
th
at
 it
 w
as
 h
el
pf
ul
 h
av
in
g 
th
is
 q
ue
st
io
n 
in
cl
ud
ed
 a
nd
 4
/1
0 
U
K
 p
at
ie
nt
s 
w
ro
te
 o
th
er
 s
ym
pt
om
s
Ye
s, 
I f
in
d 
th
at
 g
oo
d,
 b
ec
au
se
 th
er
e 
m
ay
 b
e 
th
in
gs
 th
at
 a
re
 n
ot
 li
st
ed
. (
G
er
m
an
y,
 fe
m
al
e 
ag
ed
 6
5 
ye
ar
s)
Pl
ea
se
 li
st
 a
ny
 o
th
er
 
sy
m
pt
om
s 
no
t 
m
en
tio
ne
d 
ab
ov
e,
 
an
d 
tic
k 
on
e 
bo
x 
to
 
sh
ow
 h
ow
 t
he
y 
ha
ve
 
af
fe
ct
ed
 y
ou
 o
ve
r 
th
e 
pa
st
 3
 d
ay
s
Q
3.
 O
ve
r 
th
e 
pa
st
 
3 
da
ys
, h
av
e 
yo
u 
be
en
 
fe
el
in
g 
an
xi
ou
s 
or
 
w
or
ri
ed
 a
bo
ut
 y
ou
r 
ill
ne
ss
 o
r 
tr
ea
tm
en
t?
N
o,
 n
ot
 a
t 
al
l
O
cc
as
io
na
lly
So
m
et
im
es
M
os
t 
of
 t
he
 t
im
e
Y
es
, a
lw
ay
s
G
oo
d 
co
m
pr
eh
en
si
on
 b
y 
al
l p
ar
tic
ip
an
ts
O
ve
r 
th
e 
p
as
t 
3 
da
ys
Q
3.
 H
av
e 
yo
u 
be
en
 
fe
el
in
g 
an
xi
ou
s 
or
 
w
or
ri
ed
 a
bo
ut
 y
ou
r 
ill
ne
ss
 o
r 
tr
ea
tm
en
t?
N
o
t 
at
 a
ll
O
cc
as
io
na
lly
So
m
et
im
es
M
os
t 
of
 t
he
 t
im
e
A
lw
ay
s
Q
4.
 O
ve
r 
th
e 
pa
st
 
3 
da
ys
, h
av
e 
an
y 
of
 
yo
ur
 fa
m
ily
 o
r 
fr
ie
nd
s 
be
en
 a
nx
io
us
 o
r 
w
or
ri
ed
 a
bo
ut
 y
ou
?
V
ar
ia
tio
n 
in
 le
ve
l o
f i
ns
ig
ht
 in
to
 fa
m
ily
 a
nd
 fr
ie
nd
s 
w
or
ri
es
 a
nd
/o
r 
an
xi
et
ie
s 
(3
/2
5)
Th
at
’s 
so
m
et
hi
ng
 I 
ca
n’
t r
ea
lly
 q
ua
nt
ify
 b
ec
au
se
 w
he
n 
I t
al
k 
of
 fa
m
ily
 …
 y
ou
’re
 ta
lk
in
g 
of
 a
 g
ro
up
 o
f p
eo
pl
e 
…
 A
nd
 d
iff
er
en
t c
op
in
g 
m
ec
ha
ni
sm
s 
ho
w
 …
 I 
ca
n’
t q
ua
nt
ify
 th
at
. (
U
K
, f
em
al
e 
ag
ed
 4
7 
ye
ar
s)
15
/1
5 
of
 G
er
m
an
 p
ar
tic
ip
an
ts
 fe
lt 
fa
m
ily
/fr
ie
nd
s 
w
as
 c
le
ar
; h
ow
ev
er
, 2
/1
0 
U
K
 p
at
ie
nt
s 
w
er
e 
un
ce
rt
ai
n 
ab
ou
t 
w
ho
 s
ho
ul
d 
be
 in
cl
ud
ed
 in
 ‘f
am
ily
 o
r 
fr
ie
nd
s’
Q
4.
 H
av
e 
an
y 
of
 
yo
ur
 fa
m
ily
 o
r 
fr
ie
nd
s 
be
en
 a
nx
io
us
 
or
 w
or
ri
ed
 a
bo
ut
 
yo
u?
Q
5.
 O
ve
r 
th
e 
pa
st
 
3 
da
ys
, h
av
e 
yo
u 
be
en
 
fe
el
in
g 
de
pr
es
se
d?
8/
10
 o
f U
K
 p
ar
tic
ip
an
ts
 h
ad
 a
 v
er
y 
go
od
 u
nd
er
st
an
di
ng
 o
f t
he
 w
or
d 
de
pr
es
se
d
To
 b
e 
de
pr
es
se
d 
…
 u
m
 …
 to
 b
e 
in
 d
ar
kn
es
s 
an
d 
se
e 
no
 li
gh
t a
t a
ll 
…
 A
nd
 y
ou
r 
w
ho
le
 b
ei
ng
 is
 b
la
ck
. (
U
K
, 
fe
m
al
e 
ag
ed
 7
0 
ye
ar
s)
4/
15
 o
f G
er
m
an
 p
ar
tic
ip
an
ts
 h
ad
 c
om
pr
eh
en
si
on
 p
ro
bl
em
s 
w
ith
 t
he
 w
or
d 
‘n
ie
de
rg
es
ch
la
ge
n’
 a
nd
 
m
ad
e 
su
gg
es
tio
ns
 fo
r 
al
te
rn
at
iv
es
Q
5.
 H
av
e 
yo
u 
be
en
 
fe
el
in
g 
de
pr
es
se
d?
in
 G
er
m
an
 v
er
si
on
 
al
te
rn
at
iv
e 
te
rm
 fo
r 
‘n
ie
de
rg
es
ch
la
ge
n’
: 
‘t
ra
ur
ig
 b
ed
rü
ck
t’
T
ab
le
 2
. (
C
on
tin
ue
d)
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Pr
ot
ot
yp
e 
IP
O
S 
ite
m
s
Pr
ot
ot
yp
e 
IP
O
S 
an
sw
er
 o
pt
io
ns
A
sp
ec
ts
 id
en
tif
ie
d 
w
ith
 s
up
po
rt
in
g 
qu
ot
at
io
ns
R
ev
is
ed
 IP
O
S 
ite
m
s
R
ev
is
ed
 IP
O
S 
an
sw
er
 o
pt
io
ns
Q
6.
 O
ve
r 
th
e 
pa
st
 
3 
da
ys
, h
av
e 
yo
u 
fe
lt 
go
od
 a
bo
ut
 y
ou
rs
el
f 
as
 a
 p
er
so
n?
Y
es
, a
ll 
th
e 
tim
e.
M
os
t 
of
 t
he
 t
im
e
So
m
et
im
es
O
cc
as
io
na
lly
N
o,
 n
ot
 a
t 
al
l
G
er
m
an
y 
pa
rt
ic
ip
an
ts
 in
te
rp
re
te
d 
th
e 
te
rm
 u
se
d 
in
 G
er
m
an
 m
os
tly
 a
s 
fe
el
in
g 
‘p
hy
si
ca
lly
 w
el
l’ 
or
 
‘w
el
l i
n 
su
rr
ou
nd
in
gs
’, 
an
d 
if 
as
ke
d 
di
d 
no
t 
as
so
ci
at
e 
it 
w
ith
 a
 s
pi
ri
tu
al
 a
sp
ec
t 
(9
/1
5)
Fo
r 
m
e 
fe
el
in
g 
go
od
 w
ou
ld
 b
e 
st
an
di
ng
 u
p,
 w
al
ki
ng
 …
 a
nd
 p
la
yin
g 
te
nn
is 
an
d 
no
rm
al
 li
vin
g.
 …
 R
el
at
ive
ly,
 
I f
ee
l g
oo
d,
 I 
do
 n
ot
 h
av
e 
pa
in
 a
t t
he
 m
om
en
t, 
bu
t g
en
er
al
ly 
th
e 
sit
ua
tio
n 
is 
cr
ap
. (
G
er
m
an
y,
 m
al
e 
ag
ed
 
75
 ye
ar
s)
3/
10
 o
f U
K
 p
ar
tic
ip
an
ts
 fo
un
d 
th
e 
qu
es
tio
n 
st
ra
ng
e 
to
 b
e 
as
ke
d 
an
d 
co
nf
us
in
g
H
ow
 c
an
 y
ou
 fe
el
 g
oo
d 
ab
ou
t y
ou
rs
el
f w
he
n 
yo
u’
re
 ly
in
g 
in
 h
os
pi
ta
l …
 e
ve
ry
th
in
g’
s 
cr
ap
. (
U
K
, 1
00
7)
O
h 
I u
nd
er
st
oo
d 
th
e 
qu
es
tio
n 
bu
t I
 ju
st
 d
id
n’
t k
no
w
 w
ha
t t
o 
pu
t d
ow
n 
…
 (
U
K
, f
em
al
e 
ag
ed
 4
3 
ye
ar
s)
Q
6.
 H
av
e 
yo
u 
fe
lt
 
at
 p
ea
ce
?
A
lw
ay
s
M
o
st
 o
f t
he
 t
im
e
S
o
m
et
im
es
O
cc
as
io
na
lly
N
o
t 
at
 a
ll
Q
7.
 O
ve
r 
th
e 
pa
st
 
3 
da
ys
, h
av
e 
yo
u 
be
en
 a
bl
e 
to
 s
ha
re
 
ho
w
 y
ou
 a
re
 fe
el
in
g 
w
ith
 y
ou
r 
fa
m
ily
 o
r 
fr
ie
nd
s?
Y
es
, a
s 
m
uc
h 
as
 I 
w
an
te
d
M
os
t 
of
 t
he
 t
im
e
So
m
et
im
es
O
cc
as
io
na
lly
N
ot
 a
t 
al
l w
ith
 a
ny
on
e
G
oo
d 
co
m
pr
eh
en
si
on
 b
y 
23
/2
5 
pa
rt
ic
ip
an
ts
Ye
s 
…
 I’
ve
 b
ee
n 
ab
le
 to
 s
ha
re
 h
ow
 I 
fe
el
 …
 M
os
t o
f t
he
 ti
m
e.
 (
U
K
, f
em
al
e 
ag
ed
 6
5 
ye
ar
s)
A
ns
w
er
 o
pt
io
ns
 c
au
se
d 
co
nf
us
io
n 
to
 2
/1
0 
U
K
 p
ar
tic
ip
an
ts
Q
7.
 H
av
e 
yo
u 
be
en
 
ab
le
 t
o 
sh
ar
e 
ho
w
 
yo
u 
ar
e 
fe
el
in
g 
w
ith
 y
ou
r 
fa
m
ily
 o
r 
fr
ie
nd
s 
as
 m
uc
h 
as
 
yo
u 
w
an
te
d?
Q
8.
 O
ve
r 
th
e 
pa
st
 
3 
da
ys
, h
ow
 m
uc
h 
in
fo
rm
at
io
n 
ha
ve
 y
ou
 
an
d 
yo
ur
 fr
ie
nd
s 
be
en
 
gi
ve
n?
Fu
ll 
in
fo
rm
at
io
n/
as
 m
uc
h 
as
 I 
w
an
te
d
In
fo
rm
at
io
n 
gi
ve
n,
 m
os
t 
qu
es
tio
ns
 
ad
dr
es
se
d
In
fo
rm
at
io
n 
gi
ve
n 
at
 r
eq
ue
st
, w
ou
ld
 h
av
e 
lik
ed
 m
or
e
V
er
y 
lit
tle
 in
fo
rm
at
io
n 
gi
ve
n,
 m
os
t 
qu
es
tio
ns
 n
ot
 a
dd
re
ss
ed
N
on
e 
at
 a
ll,
 w
an
te
d 
m
or
e 
in
fo
rm
at
io
n
Q
ue
st
io
ns
 a
nd
 a
ns
w
er
 o
pt
io
ns
 c
on
si
de
re
d 
by
 6
/2
5 
pa
tie
nt
s 
to
 b
e 
to
o 
lo
ng
 o
r 
co
m
pl
ic
at
ed
In
fo
rm
ed
 ‘b
y 
w
ho
m
’ a
nd
 ‘a
bo
ut
 w
ha
t?
’ i
s 
m
is
si
ng
 (
4/
25
)
Q
ue
st
io
n 
m
is
se
d 
w
he
th
er
 in
fo
rm
at
io
n 
w
as
 w
an
te
d 
or
 n
ot
 (
U
K
, 1
/1
0)
 a
nd
 w
he
th
er
 in
fo
rm
at
io
n 
w
as
 
un
de
rs
to
od
 a
t 
th
e 
ri
gh
t 
‘le
ve
l’ 
(U
K
, 1
/1
0)
1/
10
 o
f U
K
 p
ar
tic
ip
an
ts
 fo
un
d 
it 
di
ffi
cu
lt 
to
 a
ns
w
er
 fo
r 
bo
th
 t
he
m
se
lv
es
 a
nd
 t
he
ir
 fa
m
ily
 a
nd
 fr
ie
nd
s
W
el
l I
 d
on
’t 
kn
ow
 if
 it
 w
as
 e
no
ug
h 
fo
r 
m
y 
fa
m
ily
 I 
ca
n’
t a
ns
w
er
 fo
r 
th
em
. (
U
K
, m
al
e 
ag
ed
 5
4 
ye
ar
s)
Q
8.
 H
av
e 
yo
u 
ha
d 
as
 m
uc
h 
in
fo
rm
at
io
n 
as
 
yo
u 
w
an
te
d?
Q
9.
 O
ve
r 
th
e 
pa
st
 
3 
da
ys
, h
av
e 
an
y 
pr
ac
tic
al
 m
at
te
rs
 
re
su
lti
ng
 fr
om
 y
ou
r 
ill
ne
ss
, e
ith
er
 fi
na
nc
ia
l 
or
 p
er
so
na
l b
ee
n 
ad
dr
es
se
d?
N
o 
pr
ob
le
m
s/
pr
ob
le
m
s 
be
in
g 
ad
dr
es
se
d
O
cc
as
io
na
l p
ro
bl
em
s/
pr
ob
le
m
s 
be
in
g 
ad
dr
es
se
d
So
m
e 
pr
ob
le
m
s/
pr
ob
le
m
s 
pa
rt
ly
 
ad
dr
es
se
d
Se
ve
re
 p
ro
bl
em
s/
pr
ob
le
m
s 
no
t 
ad
dr
es
se
d
O
ve
rw
he
lm
in
g 
pr
ob
le
m
s/
pr
ob
le
m
s 
no
t 
ad
dr
es
se
d 
at
 a
ll
Q
ue
st
io
n 
an
d 
an
sw
er
 o
pt
io
ns
 c
on
fu
si
ng
/d
iff
ic
ul
t 
to
 c
om
pr
eh
en
d 
(7
/2
5)
Th
ey
’re
 v
er
y 
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as too long or complicated in question 2 (symptom list), 
question 8 (information received) and question 9 (practical 
matters). In addition, a third of patients in each country 
rated the severity of the symptom instead of the degree of 
being affected by it in question 2 (symptom list).
For some questions, interviewing in the two countries 
elucidated additional aspects that were important for the 
refinement of the IPOS: The question ‘Have you felt good 
about yourself as a person?’ (Q6) had been difficult to 
translate into German as there is no equivalent phrase that 
captures the same concept. The translation used for the 
interviews was understood by most participants as feeling 
physically well or feeling well in their surroundings. This 
complemented the comments of UK patients that this 
question was strange to be asked. A UK patient noted that 
question 8 (information needs) missed whether the 
received information was wanted. There were cases when 
comments made by the German patients diverged with 
those from the UK patients: Some UK patients interpreted 
‘weakness and lack of energy’ and ‘mobility’ as similar, 
whereas all German patients had a clear understanding of 
‘mobility’. Some German patients were unsure about the 
meaning of ‘drowsiness’, while UK patients had a good 
understanding of the word. In addition, there were a few 
translation-related difficulties commented on by the 
German participants, for example, comprehension prob-
lems of the German word used for ‘depressed’.
Judgement. A judgement problem was identified in both 
countries due to the 3-day time period over which symptoms 
are sought: some participants said they were unsure how to 
answer a question when they had a fluctuation of symptom 
severity; however, all answered the questions. Five partici-
pants commented that they would prefer a longer time frame, 
for example, 7 days. In addition, three participants said that 
judging the level of insight and anxiety of family and friends 
was difficult, but all answered the question.
Acceptability/questionnaire burden, missing aspects and lay-
out. Overall, acceptability of the measure was good. Spon-
taneous comments included
Well I think it’s a good questionnaire I really do … it lets 
everybody like staff that they’ve only got to look at it and they 
know how you feel. (United Kingdom, female aged 74 years)
One patient became distressed when she talked about 
the worries of her family, but explicitly wanted to continue 
answering the questions because she thought they were 
important. One other patient found answering the ques-
tionnaire burdensome because she had problems concen-
trating. All other patients did not find it distressing or 
burdensome to answer the questions. In the United 
Kingdom, 8 of the 10 patients stated that they wanted to 
keep all questions in IPOS, one patient expanded on the 
importance and variety of all questions:
… when someone’s not well as I say it changes your whole 
system your whole … routine … and everything needed to be 
looked into properly. (United Kingdom, female aged 70 years)
One or two patients each suggested the following 
aspects to be additionally included in the questionnaire: 
ease of contacting the relevant team, experience of care, 
general well-being, insomnia and diarrhoea. We did not 
incorporate these in the refined IPOS for the following 
reasons: We recognise the importance of measuring 
patient experience of care, but intended this question-
naire to remain a PROM. The aim was to assess specific 
symptoms and concerns. Defining insomnia is difficult, 
often different types of it are described.16 Besides, an 
open list is provided for patients for not-listed symptoms, 
for example, insomnia and diarrhoea. The group agreed 
that this was sufficient, as we wanted to minimise 
respondent burden.
Finally, layout problems were identified, especially the 
difficulty of staying in the right line for questions 1, 2, 7 and 
8. The layout changed automatically due to the item refine-
ments, especially shortening/aligning of answer options.
Added value of cognitive interviewing in two languages for IPOS 
refinement. The difficult translation of ‘felt good about 
yourself as a person’ (question 6) into German and the fact 
that the chosen translation was mainly understood by 
patients as physical well-being led to detailed discussions 
between both research teams about the question’s meaning 
and intention. As the intended emphasis was on spiritual 
well-being, the question was replaced by the respective 
question from the African POS ‘Have you felt at peace?’ 
This question is a good measure of spiritual well-being in 
African PC and is highly relevant across diverse cultures 
and beliefs.17 Discussion in the team also helped to find 
concise and clear phrasing in both languages for ‘mouth 
problems’ (question 2) as well as for questions 8 (informa-
tion received) and 9 (practical matters). The items ‘weak-
ness or lack of energy’, ‘drowsiness’ and ‘poor mobility’ 
were left unchanged after extensive discussion. For this 
discussion, the partly conflicting results from the interviews 
in both languages and considerations for alternatives 
in both languages – which were deemed inferior to the 
current items – were paramount.
Discussion
The cognitive interviews conducted simultaneously in 
Germany and the United Kingdom showed that for the 
majority of patients, most questions and answer options of 
the IPOS worked well. The difficulties that were identi-
fied were mainly comprehension problems, which were 
addressed in questionnaire refinement. A judgement prob-
lem was reflected in some patients’ replies regarding the 
3-day time period over which symptoms were sought. 
These patients found it hard to judge the score if 
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symptoms were fluctuating. This corresponds with the 
findings of Bergh et al.18 in their cognitive interview study 
of the Edmonton Symptom Assessment System (ESAS), 
where patients found judging intensity ‘now’ difficult for 
fluctuating symptoms. The scoring of fluctuating symp-
toms seems to be a challenge for patients regardless of 
whether they are asked to score them ‘now’ or over a 
period of time. In accordance with the wish of some 
patients for a longer time frame than 3 days, a 7-day IPOS 
version is now also available. Generally, this problem of 
scoring fluctuating symptoms on a questionnaire illus-
trates that any questionnaire can only be one component 
of a comprehensive clinical assessment.19
Problems with retrieval or response formulation were 
not identified in this study. The absence of retrieval prob-
lems corresponds with the findings of a former cognitive 
interviewing study in PC and may be due to the short time 
period for which symptoms were sought.20 However, the 
absence of retrieval problems is important to note for this 
population, which was mostly elderly and with low func-
tional status. Another important finding was that except 
the two patients mentioned earlier, these PC patients with 
mostly poor functional status did not find it distressing or 
burdensome to complete the questionnaire, and that they 
wanted to retain all questions.
Overall, cognitive interviewing showed good compre-
hension and acceptability of the questionnaire, identified 
difficulties in its completion and helped to refine it. Enabling 
patients to shape IPOS greatly benefited the refinement. 
Cognitive interviewing of patients therefore proved a valu-
able method to reduce measurement error caused by misin-
terpretation of some questions and thereby to increase the 
questionnaire’s validity. Based on our findings, we want to 
emphasise the previously published view that cognitive 
interviewing is a valuable tool in questionnaire refinement 
and that it can be used effectively in the PC setting.20,21
To our knowledge, this is the first study in PC showing 
that simultaneous interviews in two languages can provide 
additional benefits for questionnaire refinement. 
Multinational perspectives have generally not been well 
represented in cross-national survey instruments so far.22 
This is also true for PC outcome measures despite their 
cross-national and international use. Studies that have used 
cognitive interview techniques in the development of PC 
outcome measurement instruments have done so in a sin-
gle language.18–21 In other areas of medicine, results of 
cognitive interviews in several languages have been pub-
lished.23,24 These studies, however, do not comment on the 
additional value of interviews in several languages to 
refine the tested outcome measures.
We want to emphasise that we still recommend cogni-
tive interviewing in one language first for the development 
of a questionnaire from scratch. In this study, we wanted to 
refine an already existing questionnaire, the POS. The con-
sistent results from the two countries and languages 
strengthened the credibility of the findings22 and therefore 
the evidence to inform the changes to the questionnaire. As 
Lee22 recommends, in multi-site interviews, the aim should 
also be to identify as many different problems as possible 
across different sites. As demonstrated, results that were 
only found in one of the countries, for example, regarding 
‘felt good about yourself as a person’, and conflicting 
results between the countries (e.g. regarding ‘mobility’ 
and ‘drowsiness’) added important aspects to the common 
findings. Collating the findings from interviews in the two 
languages and discussing them from two linguistic angles 
resulted in wider and deeper consideration of meaning and 
context of each item. This helped to shape the final version 
of the questionnaire, based on the patients’ perspectives in 
both countries, to the optimum.
Methodological issues, strengths and limitations. In this study, 
we combined ‘think aloud’ and probing techniques as 
advocated by cognitive interview experts.14 Thus, we tried 
to maximise the information gained – such as unantici-
pated information by the ‘think aloud’ technique and spe-
cific information, for example, regarding the wording of 
certain questions, by probing techniques – and to minimise 
interviewer-imposed bias.14 As recommended for inter-
viewing in multiple countries or languages, we used stand-
ardised probing as well as spontaneous probing, thus 
combining their respective advantages:22 Standardised 
questions maintain a level of objectivity and consistency 
of interviews across countries, while spontaneous probing 
allows flexibility to adjust the interview to the specific 
situations and different communication styles and facili-
tates more in-depth investigation into various aspects.22 
We used concurrent probing as retrospective probing was 
likely to be hindered by recall problems in this elderly 
population.20
It is debated whether ‘formal’ or ‘informal analysis’ of 
cognitive interviews is preferable.14 In this study, we used 
thematic analysis as described by Willis14 and additional 
coding applying the four categories from Tourangeau’s10 
question response model, that is, a formal approach. 
However, as argued elsewhere, questions and answer 
options that worked well and the main difficulties emerged 
without formal analysis.14,20 Analysis was performed by 
two independent researchers in each country to enhance 
the findings’ credibility.
A limitation of this study is its relatively small sample 
size. It is still debated what constitutes a ‘sufficient’ sample 
size for cognitive interviews.15,22 However, small numbers 
are common as this method is work-intensive and yields 
rich data.14,20 With our study, we met current recommenda-
tions of 5–15 respondents per language group.22 The major-
ity of respondents had cancer which questions the 
transferability of the findings to people with other life-lim-
iting diseases. However, this reflects the still high propor-
tion of patients with cancer cared for by specialist PC in 
both countries. As only three community patients were 
included in the study, the results mainly reflect the views of 
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PC in-patients. However, these patients have complex PC 
needs – as this is by definition the reason for a referral to a 
PC hospital support team or PC unit. Therefore, it seems 
adequate to base the development of a tool that aims to 
assess PC concerns mainly on the views of these patients.
Conclusion
Cognitive interviewing of patients for whom the question-
naire is intended proved a valuable tool to increase its face 
and content validity. The concurrent approach in two lan-
guages – to our knowledge the first such approach in PC 
– was beneficial. The refined version is currently undergo-
ing psychometric validation in Germany and the United 
Kingdom. Wider awareness and use of cognitive inter-
viewing in measure refinement in PC is crucial.
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Appendix 1
Topic guide
Integrated Palliative care Outcome Scale (IPOS) pilot survey (Phase I)
Objective:
•• To explore the cognitive processes used by respondents when reading, interpreting and responding to items on the 
IPOS questionnaire.
•• Introduction:
-• Study purpose, confidentiality, able to stop at any time, decline questions.
-• I’m going to show you a questionnaire and I want you to read and answer the questions one at a time.
-• We will stop and talk about each question before moving onto the next.
-• Please try to ‘think out loud’ as you read and answer the questions (DEMONSTRATE: that is, When the ques-
tion is ‘What did you have for breakfast?’, instead of answering ‘Porridge’ I would say ‘Well I was running 
late for work this morning so I picked up a croissant and a coffee on the way to work, which I ate at my desk’).
-• I will also ask you some more specific things about each question.
-• Apologies if the questions get repetitive.
-• In this study, we are less interested in your answers to the questions, but how you arrive at the answers 
 – what you think the question means, and the things you were thinking about when you chose your answer.
-• You can tell me any thoughts or views you might have about the questions.
-------------------------------------------------------- START RECORDING -------------------------------------------------------------
•• General:
-• What were you thinking about when you answered that question?
-• I noticed you hesitated before giving your answer – what were you thinking about then?
•• Comprehension: what does the respondent believe the question to be asking?
-• What does the question mean to you, in your own words?
-• What does the word XXXXXX mean to you? (if certain words are thought to be problematic)
-• How easy or difficult was it to understand this question?
-• (If problem) How would you change this question?
•• Retrieval: could they recall the information required by the question? Was the time frame suitable?
-• How well could you remember your experience when answering this question?
-• Was it easy or difficult to think about the past (week) when answering this question?
-• Would there be a different time period that would be easier to understand?
•• Judgement: is the respondent able to make an evaluation based on the information recalled?
-• What were you thinking about when you answered this question?
-• How did you arrive at your answer to that question?
-• Was that easy or hard to arrive at your answer? Why do you say that?
-• How sure are you of the answer to this question?
•• Response: is the respondent able to map their internally generated answer to a response option?
-• How did you choose your answer to this question?
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-• Was it hard or easy to select an answer from the options given?
-• Did all options make sense for this question?
•• Other:
-• Is there anything else you would like to say about this question?/The questionnaire as a whole?
-• Did you find any of the questions upsetting?/embarrassing?/inappropriate?
-• Are there any topics/questions that you would leave out of this questionnaire?
-• Are there any topics/questions that you would add to this questionnaire?
-• Do you have any thoughts about the way your answers were captured? (i.e. tablet/paper)
------------------------------------------------ THANKS + STOP RECORDING --------------------------------------------
The German topic guide additionally included some questions regarding the translation options of specific words.
